Sabra Health Care REIT, Inc. (SBRA)
NASDAQ: SBRA · Real-Time Price · USD
21.08
+0.42 (2.03%)
Aug 5, 2026, 4:00 PM EDT - Market closed
Sabra Health Care REIT Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Property Revenue | 374.63 | 374.13 | 381.5 | 376.27 | 400.59 | 396.72 |
Service and Other Revenue | 445.94 | 356.88 | 284.58 | 236.15 | 186.67 | 155.51 |
| 820.57 | 731.01 | 666.08 | 612.42 | 587.26 | 552.23 | |
Revenue Growth | 18.32% | 9.75% | 8.76% | 4.28% | 6.34% | 93.87% |
Property Expenses | 327.99 | 271.11 | 227.09 | 195.25 | 162.61 | 141.2 |
Total Property Expenses | 327.99 | 271.11 | 227.09 | 195.25 | 162.61 | 141.2 |
Gross Profit | 492.58 | 459.91 | 438.99 | 417.17 | 424.65 | 411.03 |
Selling, General & Admin | 60.15 | 53.71 | 50.07 | 47.47 | 39.57 | 34.67 |
Depreciation & Amortization Expenses | 209.43 | 187 | 169.62 | 183.09 | 187.78 | 178.99 |
Other Operating Expenses | 105.24 | 6.28 | 17.9 | 14.52 | 94.18 | 13.43 |
Operating Income | 117.76 | 212.93 | 201.4 | 172.09 | 103.11 | 183.93 |
Net Gains on Disposal of Properties | 24.22 | -3.52 | 2.1 | -76.63 | -12.01 | 12.3 |
Interest Income | 38.99 | 43.62 | 37.16 | 35.1 | 37.55 | 17.32 |
Interest Expense | -116.03 | -112.49 | -115.27 | -112.96 | -105.47 | -98.63 |
Other Non-Operating Income (Expense) | 3.57 | 16.81 | 2.34 | -1.84 | -99.54 | -226.33 |
Total Non-Operating Income (Expense) | -49.25 | -55.58 | -73.68 | -156.33 | -179.47 | -295.34 |
Pretax Income | 68.51 | 157.35 | 127.72 | 15.76 | -76.36 | -111.41 |
Provision for Income Taxes | 2.13 | 1.84 | 1.01 | 2 | 1.24 | 1.85 |
Net Income | 65.23 | 155.51 | 126.71 | 13.76 | -77.61 | -113.26 |
Minority Interest in Earnings | -0.21 | -0.1 | - | - | - | - |
Net Income to Common | 65.44 | 155.61 | 126.71 | 13.76 | -77.61 | -113.26 |
Net Income Growth | -64.11% | 22.80% | 821.14% | - | - | - |
Shares Outstanding (Basic) | 248 | 241 | 233 | 231 | 231 | 219 |
Shares Outstanding (Diluted) | 251 | 244 | 236 | 233 | 231 | 219 |
Shares Change | 4.87% | 3.58% | 1.40% | 0.80% | 5.42% | 5.70% |
EPS (Basic) | 0.26 | 0.64 | 0.54 | 0.06 | -0.34 | -0.52 |
EPS (Diluted) | 0.26 | 0.64 | 0.54 | 0.06 | -0.34 | -0.52 |
EPS Growth | -65.79% | 18.52% | 800.00% | - | - | - |
Free Cash Flow | -365.86 | -145.84 | 119.4 | 137.19 | 169.06 | 214.29 |
Free Cash Flow Growth | - | - | -12.97% | -18.85% | -21.11% | 1403.37% |
Free Cash Flow Per Share | -1.46 | -0.60 | 0.51 | 0.59 | 0.73 | 0.98 |
Dividends Per Share | 1.200 | 1.200 | 1.200 | 1.200 | 1.200 | 1.200 |
Dividend Growth | 0% | 0% | 0% | 0% | 0% | -11.11% |
Gross Margin | 60.03% | 62.91% | 65.91% | 68.12% | 72.31% | 74.43% |
Operating Margin | 14.35% | 29.13% | 30.24% | 28.10% | 17.56% | 33.31% |
Profit Margin | 7.95% | 21.27% | 19.02% | 2.25% | -13.21% | -20.51% |
FCF Margin | -44.59% | -19.95% | 17.93% | 22.40% | 28.79% | 38.80% |
EBITDA | 327.19 | 399.92 | 371.02 | 355.18 | 290.89 | 362.92 |
EBITDA Margin | 39.87% | 54.71% | 55.70% | 58.00% | 49.53% | 65.72% |
EBIT | 117.76 | 212.93 | 201.4 | 172.09 | 103.11 | 183.93 |
EBIT Margin | 14.35% | 29.13% | 30.24% | 28.10% | 17.56% | 33.31% |
Effective Tax Rate | 3.11% | 1.17% | 0.79% | 12.70% | -1.63% | -1.66% |